INTRODUCTION
Dendritic cells (DCs) are a heterogeneous population of antigenpresenting cells (APCs) essential for the launching of protective T cell immunity. In humans, DCs include three major subsets with different phenotypes, tissue localizations, and functions. For example, blood and lung CD1c + DCs drive the differentiation of mucosal effector CD8 + T cells in response to influenza virus (1); blood and lung CD141 + DCs are the most potent in cross-presentation of antigens from dying cells (2-6); and blood plasmacytoid DCs (pDCs) rapidly produce abundant type I interferons (IFNs) in response to many viruses (7) . This functional specialization is determined in part by subset-specific pathogen recognition receptor expression (8) and by spatiotemporal orchestration (9) (10) (11) . However, the mechanisms that allow DC subsets to develop specialized functions remain incompletely understood (12, 13) , especially in the context of viral infection where DCs are subject to viral infection and are simultaneously key cells that activate and regulate immune response against viruses.
It is well established that DCs respond to viruses and vaccines through their innate sensors, allowing them to initiate adaptive antiviral effector T and B cell responses (12, (14) (15) (16) (17) . Extracellular viral particles engage sensors facing the extracellular and vesicular space, such as Toll-like receptors (TLRs), and the viral antigens are processed for presentation on major histocompatibility complex (MHC). Upon infection, viruses reach the cytoplasm and start replication, which provides additional antigens for presentation on MHC and activates cytosolic immune sensors (13, (18) (19) (20) . However, viral infection also leads to irreversible damage of cellular integrity and enables manipulation of immune responses by the virus (21) (22) (23) . Viral infection of DCs may also generate inflammatory mediators that can contribute to disease (24) . Studies on monocyte-derived DCs (MDDCs) showed that HIV-1 infection is restricted by SAMHD1 (25, 26) , which prevents DC activation through the cytosolic DNA sensor cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) and limits antigen presentation to T cells (19, 27, 28) . HIV-2, a virus with reduced pathogenicity compared with HIV-1 (29) , abrogates SAMHD1 restriction through its Vpx protein (27) . Accordingly, Vpx sensitizes HIV-1 infection in MDDCs and restores the ability of MDDCs to recognize the virus (19, 30) . pDCs use a Vpx-independent mechanism of resistance to HIV-1 infection (31) and respond to viral particles via a TLR7-dependent endosomal pathway (32) . In mouse models, lung DCs respond to influenza virus infection (33) and migrate to the draining lymph nodes (LNs) (34) , where they do not appear to be infected (35) . Even in the absence of viral replication, murine pDCs respond to influenza virus through TLR7 (36) (37) (38) (39) , whereas bone marrow-derived DCs use the cytosolic nucleic acid sensor retinoic acid-inducible gene I (RIG-I) (21) . In humans, infection of blood DCs by influenza virus impairs their cross-presentation ability (37, 38) , and pDCs resist influenza virus infection through an unknown mechanism (37) .
The following question thus arises: How do DCs balance the need to acquire antigen with avoidance of viral targeting and its detrimental consequences to promote protective antiviral immunity? To address this question, we used functional in vitro and genetic approaches in human blood-derived and tissue-resident DCs to evaluate DC subtypespecific functional responses to two human pathogenic RNA viruses: HIV and influenza virus.
RESULTS

Differential susceptibility of human DC subsets to HIV and influenza virus infection Blood CD1c
+ DCs, CD141 + DCs, and pDCs were sorted from healthy donors (Fig. 1A and fig. S1A ) and exposed to viruses. Upon infecting the cells with titrated doses of a CCR5-tropic HIV-2 reporter virus that encodes green fluorescent protein (GFP) instead of Nef [molecular clone JK7312As, HIV-2(JK) herein] (fig. S1B) (40) , CD1c
+ DCs became infected at titers similar to those of susceptible reporter GHOST cells ( fig. S1C ). CD141 + DCs and pDCs showed substantially lower frequencies of GFP-expressing cells (4.6-and 2-fold, respectively) (Fig. 1 , B and C, and fig. S1, C and D). As expected, an intact Vpx gene was required for infection of all DC subsets by HIV-2, indicating that SAMHD1 is an active restriction factor in all blood DC subsets (fig. S1, E and F). All blood DCs were refractory to infection by both CXCR4-tropic HIV-1 [HIV-1(NL4-3)] and CCR5-tropic HIV-1 [HIV-1(BaL)], which lacks Vpx (Fig. 1, D and E, fig. S1G ). Including the Vpx protein in viral particles increased the susceptibility of CD1c + DCs to HIV-1 infection, but CD141 + DCs and pDCs remained resistant ( Fig. 1, D and E, fig. S1 , G to I).
We next examined infection with influenza A virus. Blood CD1c + and CD141 + DCs were infected with recombinant live influenza virus H1N1 carrying a GFP reporter gene in the NS1 segment [FluA(PR8) herein] (41). CD1c + DCs became infected, whereas CD141 + DCs were comparatively resistant (Fig. 1, F S2 , B and C). Thus, the resistance of CD141 + DCs was independent of type I IFN-induced antiviral state.
We next examined steps of the viral infection cycle. We measured the ability of HIV to fuse with the cell membrane using the betalactamase (BlaM)-Vpr reporter assay ( Fig. 2A) (44) . HIV-1(BaL) and HIV-1(NL4-3) fused efficiently with CD1c + DCs but not with CD141 + DCs and pDCs (Fig. 2, A and B, and fig. S2D ). All DC subsets expressed the HIV receptors CD4, CCR5, and CXCR4 ( fig. S2E ) at variable levels that did not correlate with the resistance of the cells, suggesting that reduced receptor levels were not responsible for the reduced efficiency of viral fusion in CD141 + DCs and pDCs ( fig. S2E ). The quantity of cell-associated HIV-1 p24 protein was also similar between DC subsets at the time of the fusion assay, indicating that lower viral internalization also does not account for reduced fusion ( fig. S2F ).
We next examined the localization of a GFP-labeled virus, HIV-1(V3R5) Gag-iGFP (interdomain GFP), within the cells. In CD1c + DCs, GFP-enriched puncta and diffuse, low-level staining in the cytosol were observed, suggestive of viral fusion that resulted in GFP dispersion from viral particles (Fig. 2C and fig. S2G ). Using CCR5 antagonists that prevent viral fusion but preserve incoming viral particles, we confirmed that the diffuse cytosolic staining was abrogated, whereas the GFP-enriched puncta remained, indicating retention of the virus in endocytic compartments (Fig. 2, C and D, and fig. S2H ). In CD141 + DCs, the virus exclusively accumulated in puncta, whereas diffuse cytosolic staining was not detectable, consistent with an inhibition of viral fusion in this subset (Fig. 2, C and D, and fig. S2H ). In pDCs, the resolution was too low to unequivocally distinguish cytoplasmic staining. We next measured SAMHD1 protein levels after infection because its degradation induced by Vpx also requires viral fusion. In CD1c + DCs, SAMHD1 was degraded in most cells (fig. S2, I and J). In contrast, most CD141 + DCs and pDCs remained positive for SAMHD1 (fig. S2, I and J). We also evaluated the progression of the viral cycle by measuring the amount of reverse-transcribed DNA species. All viral DNA species were reduced in CD141 + DCs and pDCs compared with CD1c + DCs ( fig. S2K ). These results indicate that HIV is endocytosed in all DC subsets, but in CD141 + DCs and pDCs, viral fusion and entry are inhibited.
Next, we examined at which step infection by the influenza virus is inhibited in CD141 + DCs. CD1c + and CD141 + DCs showed similar levels of 2,3-and 2,6-linked sialic acid, which are receptors for influenza virus entry (Fig. 2E ). To determine whether viral fusion was inhibited, we used H1N1-pseudotyped lentivector [lenti(H1N1)]. Infection of CD141 + DCs and pDCs by lenti(H1N1) was reduced compared with that of CD1c + DCs, recapitulating our results using FluA(PR8) (Fig. 2F and fig. S2L ). Using the BlaM-Vpr assay, we found that CD1c + DCs fused efficiently with the virus, whereas viral fusion was reduced in CD141 + DCs and pDCs ( Fig. 2G and fig. S2L ). Thus, CD141 + DC and pDC resistance to influenza virus can be partly attributed to reduced fusion of the virus with the cell, similar to that observed with HIV.
Broad resistance of CD141 + DCs to infection by enveloped viruses
Because resistance occurs after endocytosis but before viral fusion, we examined how the viral envelope could influence infection of DC subtypes. Vesicular stomatitis virus (VSV) and herpes simplex virus (HSV-1) are enveloped endocytic viruses, modified vaccinia Ankara (MVA) is a membrane-fusing enveloped live-attenuated vaccine strain (45, 46) , and adenovirus (AdV) is a nonenveloped virus. CD141 + DCs and pDCs were largely resistant to infection-induced cell death by GFP reporter VSV (47) and HSV, and the fraction of GFP + cells was reduced twofold compared with CD1c + DCs (Fig. 2 , H to L, and fig. S2M ). CD141 + DCs and pDCs were also largely resistant to infection by VSV glycoprotein (VSVG)-pseudotyped lentivector ( fig. S1 , E, F, and K) and to viral fusion mediated by VSVG (Fig. 2L and fig. S2N (48) . We found that RAB15 was the only RAB selectively expressed in both CD141 + DCs and pDCs ( Fig. 3A and fig.  S3A ). RNA sequencing (RNA-seq) and reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis confirmed the selective expression of RAB15 in CD141 + DCs and pDCs and its paucity in CD1c + DCs (Fig. 3A) . We first tested the impact of ectopic expression of RAB15 (Fig. 3B) . In CD1c + DCs, transduction of a GFP-RAB15 lentivector resulted in low expression of GFP-RAB15 and a small but significant decrease in infection with H1N1-and VSVG-pseudotyped viruses. To obtain cells with higher levels of RAB15 ectopic expression, we transduced monocytic THP-1 cells with blue fluorescent protein (BFP)-RAB15 or either BFP alone or the endosomal guanosine triphosphatase (GTPase) BFP-RAB5A as controls and sorted high from low BFP expressers. RAB15 overexpression in THP-1 cells reduced viral infection and infection-induced cell death after exposure to HIV-2(JK), influenza virus, VSV, HSV-1 (Fig. 3B) , and lentivectors pseudotyped with VSVG or H1N1 ( fig. S3B ). Expression of RAB15 AN1, a splicing variant of RAB15 that lacks the CXC domain required for membrane binding (49), completely and specifically abrogated infection and fusion by influenza virus H1N1 and H1N1-pseudotyped virus ( fig. S3 , C to J).
To understand how RAB15 limits viral infection, we first examined its localization. In THP-1 cells, BFP-RAB15 colocalized with the Golgi marker GM130 (Fig. 3C) . We then investigated the localization of HIV-1(BaL) and H1N1-pseudotyped lentivector [lenti(H1N1)] in CD1c + DCs and CD141 + DCs and found that the two viruses were enriched in GM130 + compartments, specifically in CD141 + DCs (Fig. 3,  D to F, and fig. S3 , K and L). Last, we sought to test whether endogenous RAB15 contributed to the resistance of CD141 + DCs to viral infection. To circumvent the challenge of low numbers of CD141 + DCs that can be isolated from human blood (Fig.  1A) , we generated CD141 + DCs ex vivo from CD34 + hematopoietic progenitor cell cultures (50) . This system also gen er ates CD11c + DCs that are similar to MDDCs (Fig. 3G) . Compared with CD11c + DCs, CD141 + DCs showed partial re sistance to HIV-1(BaL) and lenti(H1N1) infection (Fig. 3H) . In contrast, short hair pin RNA (shRNA)-mediated knockdown of endogenous RAB15 significantly increased the frequency of infected cells for HIV-1(BaL) and H1N1-pseudotyped . ns, not significant; SSC, side scatter. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
lentivector in CD34-derived CD141 + DCs ( Fig. 3I and fig. S3M ). CD141 + cell differentiation was not affected (Fig. 3G and fig. S3N ).
CD141 + DCs sense HIV and influenza in the absence of infection
The resistance of CD141 + DCs to HIV and influenza virus infection prompted us to test the role of innate sensing in the overall response to viral exposure. In response to HIV-2 (JK) or HIV-1(BaL) Vpx, CD1c + DCs up-regulated CD86 and produced IP-10, indicating activation of an innate immune response in the DCs, and this induction was reduced by inhibitors of viral infection (Fig. 4A and fig. S4, A and B) . CD141 + DCs and pDCs also responded to HIV-2(JK) or HIV-1(BaL) Vpx, as shown by the induction of IP-10 in both subsets and CD86 in CD141 + DCs, but the response was not affected by viral infection inhibitors ( Fig. 4A  and fig. S4, A and B) . These results suggest a functional dissociation of innate sensing from viral infection selectively in CD141 + DCs and pDCs.
We next addressed the contribution of endosomal TLRs to innate sensing of HIV. pDCs respond to HIV-1 RNA through TLR7 (32) , and TLR8 can signal in response to HIV-derived RNA (51). We detected expression of TLR8 protein in CD1c + and CD141 + DCs but not pDCs, whereas TLR7 protein was expressed in all DC subsets ( Fig. 4B and  fig. S4C ). We used a furin antagonist (DC1) that inhibits TLR7 and TLR8 activity by preventing cleavage (52, 53) . DC1 prevented responses of pDCs to CL264, a TLR7 agonist ( fig. S4D ). Furin inhibition abrogated the response of CD141 + DCs and pDCs to infection with HIV-1(BaL) Vpx but not the response of CD1c + DCs (Fig. 4C and fig. S4E ). This prompted us to test the putative role of cGAS in CD1c + DCs. cGAS was detectable at different levels in all DC subsets (Fig. 4D  and fig. S4F ). shRNA-mediated knockdown of cGAS ( fig. S4G) (27) prevented CD86 upregulation by CD1c + DCs after infection by HIV-1(BaL) Vpx (Fig. 4, E and F) . Responses to cGAMP, a product of cGAS, and susceptibility to infection by the virus remained intact upon cGAS knockdown (Fig. 4, E and F,  and fig. S4H ). Thus, the response of CD1c + DCs to HIV-1 requires infection for cytosolic sensing, whereas CD141 + DCs respond to HIV-1 in the absence of infection.
We next examined DC responses to influenza virus using ultraviolet (UV) inactivation or amantadine to inhibit influenza virus entry and infection (Fig. 4G) (54) . CD1c + DCs for 24 hours alone or in the presence of the furin inhibitor DC1 (n = 5 donors from two independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
were susceptible to influenza virus infection, whereas CD141 + DCs were largely resistant. CD1c + and CD141 + DCs induced IP-10 in response to influenza virus, and this was inhibited by UV treatment or amantadine, indicating that an intact virus is required for infection (Fig. 4G ). IFNs were induced in CD1c + DCs and were below limit of detection in CD141 + DCs ( fig. S4I ), but the ability of B18R to reduce CD86 induction in response to influenza virus suggests that IFNs were also induced in CD141 + DCs (fig. S2M) . To determine the contribution of TLR sensing to DC activation and response, we moved to serum-free medium to limit serum-induced CD141 + DC activation. In these conditions, CD141
+ DCs expressed CD86 and induced IP-10 in response to influenza virus, and both were inhibited by DC1 treatment (Fig. 4H) . These results show that CD141 + DCs are capable of innate, TLR-mediated sensing of influenza virus despite being resistant to overall infection.
DC infection determines T cell responses to HIV and influenza virus Because viral infection was essential for innate sensing in CD1c
+ DCs but not CD141 + DCs, we examined how infection could determine antigen presentation to T cells by the DCs. For HIV, we used a CD8 + T cell line specific to a structural antigen of HIV-1 (SL9 in Gag). CD1c + DCs activated SL9-specific CD8 + T cells more efficiently than CD141 + DCs after infection by HIV-1 with Vpx ( Fig. 5A and fig.  S5A )
. T cell activation was abrogated when viral infection was blocked by RT inhibitors. pDCs did not activate CD8 + T cells after infection (fig. S5B). All DC subsets activated CD8 + T cells in response to a synthetic SL9 peptide (fig. S5C). Thus, infection of CD1c
+ DCs by HIV is essential for viral antigen presentation to CD8 + T cells. To examine antigen presentation by blood DCs in response to influenza virus, we generated CD8 + T cell lines specific to the structural protein M1 and nonstructural protein NS1 (fig. S5, D and E) . M1 is present in viral particles and is expressed in infected cells. CD1c + DCs induced activated M1-specific CD8 + T cells more efficiently than CD141 + DCs (Fig. 5B) . NS1 is present in productively infected cells but not in the viral particles. Only CD1c + DCs induced IFN- in NS1-specific CD8 + T cells (Fig. 5B) . To test the requirement for viral infection, we used the endosomal acidification inhibitor chloroquine, which inhibits influenza virus fusion. Chloroquine inhibited infection of CD1c + DCs by FluA(PR8) and the M1-and NS1-specific T cell activation, but it did not inhibit activation of M1-specific T cells by CD141 + DCs in response to viral particles (Fig. 5B) . Chloroquine had no effect on peptide presentation by CD1c + DCs ( fig. S5, F 
and G). Thus, viral infection is required in CD1c
+ DCs for efficient virus-specific CD8 + T cell activation to both structural and nonstructural viral antigens. In contrast, CD141 + DCs are resistant to viral infection, but this restricts their presentation on MHC to the antigens present in the viral particles.
Virus infection and antigen presentation are mutually exclusive in CD1c
+ DCs We next sought to understand how CD1c + DCs could simultaneously activate CD8 + T cells and sustain a viral infection. In HIV-1-infected cells, the Nef protein down-regulates class I MHC (22) . Using Nefexpressing HIV-1 and HIV-2, we confirmed that class I MHC is downregulated in a cell-intrinsic manner in infected CD1c + DCs but not in uninfected bystander CD1c + DCs (Fig. 5C ). We next examined the impact of influenza virus infection on viability and immunostimulatory molecule expression. In response to influenza virus infection, GFP + CD1c + DCs preferentially died after 24 hours (Fig. 5, D and E) .
Class I MHC and CD86 expression were down-regulated in GFP + CD1c + DCs 12 hours after infection, at a time when most cells were alive (Fig. 5, F 
to H). Thus, influenza virus inhibits immunostimulatory molecule expression in infected CD1c
+ DCs in a cell-intrinsic manner and subsequently induces cell death, whereas noninfected bystander CD1c + DCs remain unaltered. This raised the possibility that in a culture of CD1c + DCs partially infected after exposure to the virus, noninfected CD1c + DCs may also contribute to antigen presentation. To test this idea, we sorted GFP + and GFP − CD1c + DCs after infection with influenza virus and measured the expansion of autologous M1-specific CD8 + T cells. GFP − CD1c + DCs were more potent at expanding T cells than GFP + DCs (Fig. 5, I and J) . Thus, at least in vitro, viral infection in CD1c + DCs is required for antigen presentation, but the infection simultaneously impairs T cell stimulation capacity at the cellular level.
DC subset cooperation for induction of antiviral T cell responses CD141
+ DCs are thought to be specialized in cross-presentation of antigens from necrotic cells, but whether cross-presentation is an essential mode of antigen presentation by these cells is unknown (55 (Fig. 6 , A and C). In the mixed culture, viral infection was largely restricted to HLA-A2 − CD1c + DCs (Fig. 6, B and D, and fig. S6 ), recapitulating the situation with purified DC subsets. HLA-A2 + CD141 + DCs were inefficient at stimulating T cells after infection with influenza virus and HIV. The presence of HLA-A2 − CD1c + DCs during infection rescued the ability of HLA-A2 + CD141 + DCs to efficiently present HIV-1 or influenza virus antigen (Fig. 6, B and E). These in vitro results support the notion that CD141 + DCs depend on viral antigen produced in bystander-infected cells, such as CD1c + DCs, for efficient T cell stimulation.
Resistance of CD141 + to influenza virus infection in vivo
To validate the findings in tissue-resident DCs, we infected sorted human lung DCs with influenza virus. Similar to blood-derived DCs, human lung CD1c + DCs were susceptible to FluA(PR8) infection ex vivo, whereas lung CD141 + DCs were comparatively resistant (Fig. 7,  A and B) . To determine susceptibility to infection in vivo, we infected humanized mice with GFP reporter influenza virus through the intranasal route (Fig. 7C) . In the lung, both CD1c + and CD141 + DCs became GFP + over time, likely reflecting productive infection in CD1c + DCs and antigen capture in CD141 + DCs (Fig. 7D and fig. S7A ), although we cannot exclude the idea that CD141 + DCs may carry some undetectable level of intracellular and postfusion viral material that failed to replicate. In contrast, only CD141 + DCs carried GFP + material in the draining LNs (Fig. 7E and fig. S7B ). after infection (Fig. 6D) . Analysis of HA expression within lung GFP + CD141 + DCs and GFP + CD1c + DCs confirmed the much-reduced level of HA expression on CD141 + DCs (Fig. 7, G and H) . In the draining LNs, GFP + CD141 + DCs remained uninfected (Fig. 7, I and J). These results in tissue-resident DCs recapitulate our in vitro observations on differential susceptibility of DC subsets to viral infection, thereby supporting the notion that the functional specialization of DC subsets for viral infection applies to both circulating blood DCs and tissueresident DCs.
DISCUSSION
Infection of DCs with viruses can be considered a dilemma for the immune system: It allows activation of the innate and adaptive immune response, but it simultaneously facilitates manipulation by the viruses of the immune system itself. We show that this paradox is resolved by dissociation of viral infection from viral antigen presentation to T cells across DC subsets. Blood and lung DC subsets display differential susceptibility and selective resistance to infection with influenza virus (blood and lung DCs), as well as HIV, VSV, and HSV (blood in (I) (n = 2; two different donors combined from two independent experiments). MFI, mean fluorescence intensity. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
DCs). CD1c + DCs are permissive to viral fusion by influenza virus and HIV, support viral infection and cytosolic sensing, and generate viral antigen that is needed to launch T cell responses but also rapidly die because of the infection. In contrast, CD141 + DCs resist viral entry and rely on virus-infected CD1c + DCs (and other cell types) as source of antigen for crosspresentation to promote activation of T cells (Fig. 7K) . We propose that this resistance of CD141 + DCs to viral entry is a mechanism to avoid the deleterious effects of viral infection while preserving the functional capacity of DCs to launch T cell stimulation and subsequent cell-mediated immunity.
Given the critical role of DCs in the induction of antiviral immunity, it is remarkable that CD141
+ DCs resist such a broad range of viruses. Nonetheless, our observations do not preclude the possibility of variable infectivity of individual viruses toward CD141 + DCs, given that additional virus-specific factors and mechanisms could play an additive role. Influenza virus and VSV are pH-dependent and require viral internalization followed by acidification in the endosomes (56) . Entry of HIV-1 is pH-independent (57), but endocytosis before viral fusion has been extensively documented in primary CD4 + target cells (58) (59) (60) . HIV receptor levels are reduced on CD141 + DCs compared with CD1c + DCs, but receptor levels did not correlate with the pattern of resistance among subsets and thus are not the dominant factor explaining the broad resistance of CD141 + DCs. Our results demonstrate an essential role for RAB15 in the resistance of CD141 + DC (and pDC). RAB15 appears to define a distinct antiviral resistance pathway based on constitutive and selective expression in CD141 + DCs and pDCs. HIV-1 and influenza-pseudotyped virus accumulated in GM130 + compartments in CD141 + DCs. This correlates with the localization of RAB15 after ectopic expression, suggesting that viral particles undergo a retrograde transport and/or accumulation into the Golgi that impairs their fusogenic capacity in a RAB15-dependent manner. The transit and maturation of viral envelope glycoproteins and cellular receptors during their biogenesis, in the absence of recognized Golgi-to-Golgi fusion, support the idea that the Golgi apparatus may be a privileged compartment with intrinsic resistance to viral envelope protein-mediated fusion. It is possible that other endocytic enveloped viruses, such as respiratory syncytial virus, evade this mechanism of antiviral resistance (61, 62) . Neutralization of type I IFN had a marginal ability to rescue infection in to DCs 12 hours after infection with GFP-tagged FluA(PR8) (MOI = 2; n = 3 combined from two experiments). **P < 0.01, ***P < 0.001, ****P < 0.0001.
pDCs, which contrasts with the prevailing view that the resistance of pDCs to viral infection would be mediated by autocrine type I IFN production.
Although we have identified a key role for RAB15 in promoting resistance of CD141 + DCs to viral infection, how resistance is achieved at the biochemical level remains to be determined. It is possible that CD1c + DCs express specific gene programs that render them susceptible to viral infection in a way that overcomes RAB15 activity. An interesting scenario is that ISG expression in CD1c + DCs is not sufficient to impose an antiviral state and that CD1c + DCs are equipped with specific programs that enable viral replication. A similar concept has been proposed for marginal zone macrophages (63) . Alternatively, RAB15 might depend on specific effectors and cofactors that are also expressed selectively in CD141 + DCs that remain to be identified. How RAB15 may increase virus localization in GM130 + compartments and how the Golgi apparatus may limit virus-mediated fusion thus need further study. Other RAB GTPases previously linked to RAB15 activity and to HIV and influenza virus infection could also be implicated (64) (65) (66) . In addition, we find that the vaccine strain MVA poxvirus infects all DC subsets, presumably through efficient fusion at the cell surface (46) . The ability to bypass RAB15-mediated resistance may be a desirable property for the immunogenicity of live-attenuated vaccines, such as MVA, because it would maximize production of viral antigens and triggering of cytosolic sensors within the APCs. How DCs deal with viral infection and perform antigen presentation is highly organized in space and time (1, 9, 10, 55) . Here, we have demonstrated that a mechanism enabling this dual function is a dissociation of these two events. To ensure that antigen is presented, CD141 + DCs are protected from viral infection and use cross-presentation. This paradigm may allow a better understanding of the induction of protective immunity against viruses and live-attenuated vaccines and sheds light on the existence of constitutive mechanisms of resistance to viral infection.
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